Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised PatientsMarta Francesca Di Pasquale, Milena Encheva, Victor Hugo Cambursano et al.|Clinical Infectious Diseases|2018Cited by 257
Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort studyStefano Aliberti, Ning Shen, Luis Felipe Reyes et al.|The Lancet Infectious Diseases|2016Cited by 178
Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired PneumoniaJudith Marín‐Corral, Peter Chipev, Sergi Pascual-Guàrdia et al.|CHEST Journal|2020Cited by 56
An international perspective on hospitalized patients with viral community-acquired pneumoniaDejan Radovanovic, Eric Walter Pefura Yone, Giovanni Sotgiu et al.|European Journal of Internal Medicine|2018Cited by 35
Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence studyManuela Carugati, Simone Aranha Nouér, Stefano Aliberti et al.|European Journal of Clinical Microbiology & Infectious Diseases|2020Cited by 34